Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Receivables (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Receivables for 2 consecutive years, with $10.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables changed N/A to $10.4 million in Q4 2025 year-over-year; TTM through Oct 2025 was $10.4 million, a N/A change, with the full-year FY2025 number at $8.1 million, up 304.45% from a year prior.
  • Receivables was $10.4 million for Q4 2025 at Kestra Medical Technologies, up from $9.2 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $10.4 million in Q4 2025 to a low of $2.0 million in Q2 2024.